Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Hepatobiliary Pancreat Dis Int ; 21(1): 33-40, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34366198

RESUMO

BACKGROUND: Apoptosis, also called programmed cell death, is a genetically controlled process against hyperproliferation and malignancy. The Fas-Fas ligand (FasL) system is considered a major pathway for apoptosis in cells and tissues. Thus, this study aimed to investigate whether single nucleotide polymorphisms (SNPs) in Fas and FasL gene may have effects on the recurrence and survival of patients with hepatocellular carcinoma (HCC) after curative hepatectomy. METHODS: We investigated the relationship between Fas rs1800682, rs2234767 and FasL rs763110 polymorphisms and recurrence-free survival (RFS) as well as overall survival (OS) in 117 Chinese Han patients with HCC who underwent hepatectomy. RESULTS: In Kaplan-Meier survival analysis, only Fas rs1800682 (-670 A/G) was associated with RFS and OS. Compared with AA genotype, the AG/GG genotype was significantly associated with better RFS (P = 0.008) and OS (P = 0.020). Moreover, multivariate Cox regression analysis showed that Fas rs1800682 remained as a significant independent predictor of RFS for HCC patients with hepatectomy [AG/GG vs. AA: adjusted hazard ratio = 0.464, 95% confidence interval: 0.275-0.782, P = 0.004], but was not an independent predictor of OS (P = 0.395). CONCLUSIONS: This study demonstrated that Fas -670 G allele may play a protective role in the recurrence and survival of HCC patients with hepatectomy. Furthermore, Fas rs1800682 polymorphism might be a promising biomarker for HCC patients after hepatectomy.


Assuntos
Carcinoma Hepatocelular/genética , Proteína Ligante Fas/genética , Neoplasias Hepáticas/genética , Receptor fas/genética , Adulto , Idoso , Povo Asiático/genética , Biomarcadores Tumorais , Carcinoma Hepatocelular/etnologia , Carcinoma Hepatocelular/cirurgia , China/epidemiologia , Feminino , Hepatectomia , Humanos , Neoplasias Hepáticas/etnologia , Neoplasias Hepáticas/cirurgia , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Prognóstico
2.
Chin J Integr Med ; 13(1): 55-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17578320

RESUMO

OBJECTIVE: To assess the effect and safety of nano-Amoni Paste (nmAP) in the treatment of children's anorexia (AR). METHODS: One hundred and eighty patients of AR were assigned according to the randomized, double-blinded, double-simulated and parallel controlled principle to three groups, the treated group (TG), the positive control group (PCG) and the negative control group (NCG), 60 in each group. The patients in TG were treated by sticking 1.5 ml of nmAP on the acupoint of Shenque (Ren 8) once a day and orally taking placebo liquid 10 ml twice a day; those in PCG and NCG treated with sticking paste of placebo on Ren 8, and oral taking of Shanmai Jianpi Oral Liquid and placebo liquid respectively, 10 ml each time twice per day. The course of treatment for all was 10 days, all patients were treated for 2 courses. RESULTS: The total effective rate and the effective rate on cardinal symptom in TG was 85.0% and 95.0% respectively, that in PCG 86.2% and 96.55% and in NCG 45.5% and 65.45%, respectively, showing significant difference between groups (P<0.05). Comparison of the clinical manifestation before and after treatment showed significant improvement in volume of food intake, appetite, complexion and reduction of restlessness symptom (P<0.05) in all three groups, and there was no adverse reaction found in them. CONCLUSION: nmAP is an effective and safe remedy for treatment of Children's anorexia.


Assuntos
Amomum/química , Anorexia/terapia , Óleos Voláteis/administração & dosagem , Fitoterapia , Extratos Vegetais/administração & dosagem , Pontos de Acupuntura , Anorexia/fisiopatologia , Apetite/efeitos dos fármacos , Estatura/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Criança , Pré-Escolar , Método Duplo-Cego , Ingestão de Alimentos/efeitos dos fármacos , Feminino , Humanos , Lipossomos , Masculino , Nanopartículas , Óleos Voláteis/efeitos adversos , Óleos Voláteis/isolamento & purificação , Óleos Voláteis/uso terapêutico , Pomadas , Extratos Vegetais/efeitos adversos , Extratos Vegetais/uso terapêutico , Agitação Psicomotora/fisiopatologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA